Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse

Fig. 3

Post-recurrence survival analysis of patients. PARPi monotherapy after secondary platinum-sensitive relapse had no adverse effect on PRS compared with platinum-based chemotherapy; Both PARPi monotherapy after secondary platinum-sensitive relapse and post-line treatment with PARPi prolonged PRS in patients compared to those without PARPi history

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us